The OncoPrint results showed that in 142 of 1084 breast cancer patients (13%), the SVIP gene had altered either amplification, deep deletion, high mRNA expression, or low mRNA expression; the most common alteration type was found to be high mRNA expression (Figure 2B). Here, SVIP is linked to breast carcinoma.